---
title: "Genenta Science S.p.A. (GNTA.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/GNTA.US.md"
symbol: "GNTA.US"
name: "Genenta Science S.p.A."
industry: "Biotechnology"
---

# Genenta Science S.p.A. (GNTA.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.genenta.com](https://www.genenta.com) |

## Company Profile

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma mul...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.15 | 266/605 | - | - | - |
| PB | 1.45 | 138/605 | 5.42 | 4.38 | 2.89 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-22T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 1 | 100% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.88 |
| Highest Target | 6.97 |
| Lowest Target | 6.97 |

## References

- [Company Overview](https://longbridge.com/en/quote/GNTA.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/GNTA.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/GNTA.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.